HIV and AIDS clinical trials?help researchers find better ways to prevent, detect, or treat HIV and AIDS. Examples of HIV and AIDS clinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV and AIDS.
This report contains market size and forecasts of HIV and AIDS Clinical Trials in Global, including the following market information:
Global HIV and AIDS Clinical Trials Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global HIV and AIDS Clinical Trials market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Phase I Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of HIV and AIDS Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc. and Bionor Holding AS, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV and AIDS Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV and AIDS Clinical Trials Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global HIV and AIDS Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Phase IV
Global HIV and AIDS Clinical Trials Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global HIV and AIDS Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical & Biopharmaceutical Companies
Non Profit Organizations
Others
Global HIV and AIDS Clinical Trials Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global HIV and AIDS Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV and AIDS Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies HIV and AIDS Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
PPD Inc.
IQVIA Inc.
Parexel International Corporation
ICON plc
Syneos Health
WuXi AppTec
Janssen Global Services, LLC
Gilead Sciences, Inc.
Bionor Holding AS
Charles River Laboratories
GSK plc.
SGS SA
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HIV and AIDS Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV and AIDS Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV and AIDS Clinical Trials Overall Market Size
2.1 Global HIV and AIDS Clinical Trials Market Size: 2022 VS 2030
2.2 Global HIV and AIDS Clinical Trials Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top HIV and AIDS Clinical Trials Players in Global Market
3.2 Top Global HIV and AIDS Clinical Trials Companies Ranked by Revenue
3.3 Global HIV and AIDS Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 HIV and AIDS Clinical Trials Companies in Global Market, by Revenue in 2022
3.5 Global Companies HIV and AIDS Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV and AIDS Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 HIV and AIDS Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV and AIDS Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global HIV and AIDS Clinical Trials Market Size Markets, 2022 & 2030
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - Global HIV and AIDS Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global HIV and AIDS Clinical Trials Revenue, 2018-2023
4.2.2 By Type - Global HIV and AIDS Clinical Trials Revenue, 2023-2030
4.2.3 By Type - Global HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HIV and AIDS Clinical Trials Market Size, 2022 & 2030
5.1.2 Pharmaceutical & Biopharmaceutical Companies
5.1.3 Non Profit Organizations
5.1.4 Others
5.2 By Application - Global HIV and AIDS Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global HIV and AIDS Clinical Trials Revenue, 2018-2023
5.2.2 By Application - Global HIV and AIDS Clinical Trials Revenue, 2023-2030
5.2.3 By Application - Global HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global HIV and AIDS Clinical Trials Market Size, 2022 & 2030
6.2 By Region - Global HIV and AIDS Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global HIV and AIDS Clinical Trials Revenue, 2018-2023
6.2.2 By Region - Global HIV and AIDS Clinical Trials Revenue, 2023-2030
6.2.3 By Region - Global HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America HIV and AIDS Clinical Trials Revenue, 2018-2030
6.3.2 US HIV and AIDS Clinical Trials Market Size, 2018-2030
6.3.3 Canada HIV and AIDS Clinical Trials Market Size, 2018-2030
6.3.4 Mexico HIV and AIDS Clinical Trials Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe HIV and AIDS Clinical Trials Revenue, 2018-2030
6.4.2 Germany HIV and AIDS Clinical Trials Market Size, 2018-2030
6.4.3 France HIV and AIDS Clinical Trials Market Size, 2018-2030
6.4.4 U.K. HIV and AIDS Clinical Trials Market Size, 2018-2030
6.4.5 Italy HIV and AIDS Clinical Trials Market Size, 2018-2030
6.4.6 Russia HIV and AIDS Clinical Trials Market Size, 2018-2030
6.4.7 Nordic Countries HIV and AIDS Clinical Trials Market Size, 2018-2030
6.4.8 Benelux HIV and AIDS Clinical Trials Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia HIV and AIDS Clinical Trials Revenue, 2018-2030
6.5.2 China HIV and AIDS Clinical Trials Market Size, 2018-2030
6.5.3 Japan HIV and AIDS Clinical Trials Market Size, 2018-2030
6.5.4 South Korea HIV and AIDS Clinical Trials Market Size, 2018-2030
6.5.5 Southeast Asia HIV and AIDS Clinical Trials Market Size, 2018-2030
6.5.6 India HIV and AIDS Clinical Trials Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America HIV and AIDS Clinical Trials Revenue, 2018-2030
6.6.2 Brazil HIV and AIDS Clinical Trials Market Size, 2018-2030
6.6.3 Argentina HIV and AIDS Clinical Trials Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV and AIDS Clinical Trials Revenue, 2018-2030
6.7.2 Turkey HIV and AIDS Clinical Trials Market Size, 2018-2030
6.7.3 Israel HIV and AIDS Clinical Trials Market Size, 2018-2030
6.7.4 Saudi Arabia HIV and AIDS Clinical Trials Market Size, 2018-2030
6.7.5 UAE HIV and AIDS Clinical Trials Market Size, 2018-2030
7 Players Profiles
7.1 PPD Inc.
7.1.1 PPD Inc. Corporate Summary
7.1.2 PPD Inc. Business Overview
7.1.3 PPD Inc. HIV and AIDS Clinical Trials Major Product Offerings
7.1.4 PPD Inc. HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.1.5 PPD Inc. Key News
7.2 IQVIA Inc.
7.2.1 IQVIA Inc. Corporate Summary
7.2.2 IQVIA Inc. Business Overview
7.2.3 IQVIA Inc. HIV and AIDS Clinical Trials Major Product Offerings
7.2.4 IQVIA Inc. HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.2.5 IQVIA Inc. Key News
7.3 Parexel International Corporation
7.3.1 Parexel International Corporation Corporate Summary
7.3.2 Parexel International Corporation Business Overview
7.3.3 Parexel International Corporation HIV and AIDS Clinical Trials Major Product Offerings
7.3.4 Parexel International Corporation HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.3.5 Parexel International Corporation Key News
7.4 ICON plc
7.4.1 ICON plc Corporate Summary
7.4.2 ICON plc Business Overview
7.4.3 ICON plc HIV and AIDS Clinical Trials Major Product Offerings
7.4.4 ICON plc HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.4.5 ICON plc Key News
7.5 Syneos Health
7.5.1 Syneos Health Corporate Summary
7.5.2 Syneos Health Business Overview
7.5.3 Syneos Health HIV and AIDS Clinical Trials Major Product Offerings
7.5.4 Syneos Health HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.5.5 Syneos Health Key News
7.6 WuXi AppTec
7.6.1 WuXi AppTec Corporate Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec HIV and AIDS Clinical Trials Major Product Offerings
7.6.4 WuXi AppTec HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.6.5 WuXi AppTec Key News
7.7 Janssen Global Services, LLC
7.7.1 Janssen Global Services, LLC Corporate Summary
7.7.2 Janssen Global Services, LLC Business Overview
7.7.3 Janssen Global Services, LLC HIV and AIDS Clinical Trials Major Product Offerings
7.7.4 Janssen Global Services, LLC HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.7.5 Janssen Global Services, LLC Key News
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Corporate Summary
7.8.2 Gilead Sciences, Inc. Business Overview
7.8.3 Gilead Sciences, Inc. HIV and AIDS Clinical Trials Major Product Offerings
7.8.4 Gilead Sciences, Inc. HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences, Inc. Key News
7.9 Bionor Holding AS
7.9.1 Bionor Holding AS Corporate Summary
7.9.2 Bionor Holding AS Business Overview
7.9.3 Bionor Holding AS HIV and AIDS Clinical Trials Major Product Offerings
7.9.4 Bionor Holding AS HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.9.5 Bionor Holding AS Key News
7.10 Charles River Laboratories
7.10.1 Charles River Laboratories Corporate Summary
7.10.2 Charles River Laboratories Business Overview
7.10.3 Charles River Laboratories HIV and AIDS Clinical Trials Major Product Offerings
7.10.4 Charles River Laboratories HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.10.5 Charles River Laboratories Key News
7.11 GSK plc.
7.11.1 GSK plc. Corporate Summary
7.11.2 GSK plc. Business Overview
7.11.3 GSK plc. HIV and AIDS Clinical Trials Major Product Offerings
7.11.4 GSK plc. HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.11.5 GSK plc. Key News
7.12 SGS SA
7.12.1 SGS SA Corporate Summary
7.12.2 SGS SA Business Overview
7.12.3 SGS SA HIV and AIDS Clinical Trials Major Product Offerings
7.12.4 SGS SA HIV and AIDS Clinical Trials Revenue in Global Market (2018-2023)
7.12.5 SGS SA Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. HIV and AIDS Clinical Trials Market Opportunities & Trends in Global Market
Table 2. HIV and AIDS Clinical Trials Market Drivers in Global Market
Table 3. HIV and AIDS Clinical Trials Market Restraints in Global Market
Table 4. Key Players of HIV and AIDS Clinical Trials in Global Market
Table 5. Top HIV and AIDS Clinical Trials Players in Global Market, Ranking by Revenue (2022)
Table 6. Global HIV and AIDS Clinical Trials Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global HIV and AIDS Clinical Trials Revenue Share by Companies, 2018-2023
Table 8. Global Companies HIV and AIDS Clinical Trials Product Type
Table 9. List of Global Tier 1 HIV and AIDS Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV and AIDS Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - HIV and AIDS Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - HIV and AIDS Clinical Trials Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - HIV and AIDS Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - HIV and AIDS Clinical Trials Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global HIV and AIDS Clinical Trials Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global HIV and AIDS Clinical Trials Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2023-2030
Table 30. PPD Inc. Corporate Summary
Table 31. PPD Inc. HIV and AIDS Clinical Trials Product Offerings
Table 32. PPD Inc. HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 33. IQVIA Inc. Corporate Summary
Table 34. IQVIA Inc. HIV and AIDS Clinical Trials Product Offerings
Table 35. IQVIA Inc. HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 36. Parexel International Corporation Corporate Summary
Table 37. Parexel International Corporation HIV and AIDS Clinical Trials Product Offerings
Table 38. Parexel International Corporation HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 39. ICON plc Corporate Summary
Table 40. ICON plc HIV and AIDS Clinical Trials Product Offerings
Table 41. ICON plc HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 42. Syneos Health Corporate Summary
Table 43. Syneos Health HIV and AIDS Clinical Trials Product Offerings
Table 44. Syneos Health HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 45. WuXi AppTec Corporate Summary
Table 46. WuXi AppTec HIV and AIDS Clinical Trials Product Offerings
Table 47. WuXi AppTec HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 48. Janssen Global Services, LLC Corporate Summary
Table 49. Janssen Global Services, LLC HIV and AIDS Clinical Trials Product Offerings
Table 50. Janssen Global Services, LLC HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 51. Gilead Sciences, Inc. Corporate Summary
Table 52. Gilead Sciences, Inc. HIV and AIDS Clinical Trials Product Offerings
Table 53. Gilead Sciences, Inc. HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 54. Bionor Holding AS Corporate Summary
Table 55. Bionor Holding AS HIV and AIDS Clinical Trials Product Offerings
Table 56. Bionor Holding AS HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 57. Charles River Laboratories Corporate Summary
Table 58. Charles River Laboratories HIV and AIDS Clinical Trials Product Offerings
Table 59. Charles River Laboratories HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 60. GSK plc. Corporate Summary
Table 61. GSK plc. HIV and AIDS Clinical Trials Product Offerings
Table 62. GSK plc. HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
Table 63. SGS SA Corporate Summary
Table 64. SGS SA HIV and AIDS Clinical Trials Product Offerings
Table 65. SGS SA HIV and AIDS Clinical Trials Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. HIV and AIDS Clinical Trials Segment by Type in 2022
Figure 2. HIV and AIDS Clinical Trials Segment by Application in 2022
Figure 3. Global HIV and AIDS Clinical Trials Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global HIV and AIDS Clinical Trials Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global HIV and AIDS Clinical Trials Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV and AIDS Clinical Trials Revenue in 2022
Figure 8. By Type - Global HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 9. By Application - Global HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 10. By Region - Global HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 11. By Country - North America HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 12. US HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 13. Canada HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 16. Germany HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 17. France HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 19. Italy HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 20. Russia HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 24. China HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 25. Japan HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 28. India HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 30. Brazil HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa HIV and AIDS Clinical Trials Revenue Market Share, 2018-2030
Figure 33. Turkey HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 34. Israel HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 36. UAE HIV and AIDS Clinical Trials Revenue, (US$, Mn), 2018-2030
Figure 37. PPD Inc. HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. IQVIA Inc. HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Parexel International Corporation HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. ICON plc HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Syneos Health HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. WuXi AppTec HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Janssen Global Services, LLC HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gilead Sciences, Inc. HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bionor Holding AS HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Charles River Laboratories HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GSK plc. HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. SGS SA HIV and AIDS Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
